Nearly 10 years after Kara Kenan of North Carolina finished treatment for advanced breast cancer, her routine bloodwork revealed an increased level of an enzyme called alkaline phosphatase. Kenan’s primary care doctor didn’t think that was important, so he ordered no further tests. But Kenan, who directs marketing for the advocacy group Cancer Nation, knew